Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients.

Nevin F W ZakiYomna M SabriOmar FaroukAmany AbdelfatahDavid Warren SpenceAhmed Salem BaHammam Seithikurippu R Pandi-Perumal

Published in: Nature and science of sleep (2020)

Serum melatonin levels correlated significantly with self-reported sleep quality and psychometric profiles of depression in the present sample of breast cancer patients. The melatonin assay, which is relatively easy to carry out, provided a convenient, objective measure of an important biological correlate of sleep quality and depression. This assay thus represented a confirmatory alternative to the self-report instruments, which may sometimes be unreliable. Future studies should further evaluate the utility of melatonin measures in psychiatric and sleep complaints of breast cancer patients.

Keyphrases

sleep quality
depressive symptoms
physical activity
social support
high throughput
mental health
case control
single cell